Patients with active GIT bleeding.
Patients with history of bowel obstruction, perforation.
Patients with history of allergy to PEG.
Treatment with rifaximin or neomycin in the previous 7 days.
Patients with major psychiatric illness.
Patients receiving benzodiazepines and narcotics.
Patients with compromised renal.
Patients receiving medications highly bound to plasma proteins eg. Warfarin.
Pregnant or lactating women.
Fulminant hepatic failure.

NCT03100513_exc_T1
Qualifier
active
NCT03100513_exc_T2
Condition
GIT bleeding
NCT03100513_exc_T3
Condition
bowel obstruction
NCT03100513_exc_T4
Condition
owel erforation.
NCT03100513_exc_T5
Observation
history
NCT03100513_exc_T6
Scope
bowel obstruction, perforation
NCT03100513_exc_T7
Observation
history
NCT03100513_exc_T8
Condition
allergy
NCT03100513_exc_T9
Drug
PEG
NCT03100513_exc_T10
Drug
rifaximin
NCT03100513_exc_T11
Drug
neomycin
NCT03100513_exc_T12
Temporal
in the previous 7 days
NCT03100513_exc_T13
Scope
rifaximin or neomycin
NCT03100513_exc_T14
Condition
major psychiatric illness
NCT03100513_exc_T15
Drug
benzodiazepines
NCT03100513_exc_T16
Drug
narcotics
NCT03100513_exc_T17
Condition
compromised renal
NCT03100513_exc_T18
Drug
medications highly bound to plasma proteins
NCT03100513_exc_T19
Drug
Warfarin
NCT03100513_exc_T20
Condition
Pregnant
NCT03100513_exc_T21
Condition
lactating
NCT03100513_exc_T22
Person
women
NCT03100513_exc_T23
Condition
hepatic failure
NCT03100513_exc_T24
Qualifier
Fulminant